This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kansal, R. G.
Right arrow Articles by Kotb, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kansal, R. G.
Right arrow Articles by Kotb, M.

 Previous Article  |  Next Article 

Infection and Immunity, November 2000, p. 6362-6369, Vol. 68, No. 11
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Inverse Relation between Disease Severity and Expression of the Streptococcal Cysteine Protease, SpeB, among Clonal M1T1 Isolates Recovered from Invasive Group A Streptococcal Infection Cases

Rita G. Kansal,1,2 Allison McGeer,3 Donald E. Low,3 Anna Norrby-Teglund,1,2 and Malak Kotb1,2,*

Veterans Affairs Medical Center, Research Service, Memphis, Tennessee 381041; Departments of Surgery and of Microbiology and Immunology, University of Tennessee, Memphis, Tennessee 381632; and Department of Microbiology, Mount Sinai Hospital, and the University of Toronto, Toronto, Ontario, Canada M5G 1X53

Received 15 May 2000/Returned for modification 21 June 2000/Accepted 18 August 2000

The streptococcal cysteine protease (SpeB) is one of the major virulence factors produced by group A streptococci (GAS). In this study we investigated if differences exist in SpeB production by clonally related M1T1 clinical isolates derived from patients with invasive infections. Twenty-nine of these isolates were from nonsevere cases and 48 were from severe cases, including streptococcal toxic shock syndrome (STSS) and necrotizing fasciitis (NF) cases. The expression and amount of the 28-kDa SpeB protein produced were determined by quantitative Western blotting, and protease activity was measured by a fluorescent enzymatic assay. A high degree of variation in SpeB expression was seen among the isolates, and this variation seemed to correlate with the severity and/or clinical manifestation of the invasive infection. The mean amount of 28-kDa SpeB protein and cysteine protease activity produced by isolates from nonsevere cases was significantly higher than that from STSS cases (P = 0.001). This difference was partly due to the fact that 41% of STSS isolates produced little or no SpeB compared to only 14% of isolates recovered in nonsevere cases. Moreover, the cysteine protease activity among those isolates that expressed SpeB was significantly lower for STSS isolates than for isolates from nonsevere cases (P = 0.001). Increased SpeB production was also inversely correlated with intact M protein expression, and inhibition of cysteine protease activity blocked the cleavage of the surface M protein. Together, the data support the existence of both an "on-off" and a posttranslational regulatory mechanism(s) controlling SpeB production, and they suggest that isolates with the speB gene in the "off" state are more likely to spare the surface M protein and to be isolated from cases of severe rather than nonsevere invasive infection. These findings may have important implications for the role of SpeB in host-pathogen interactions via regulation of the expression of GAS virulence genes and the severity of invasive disease.

* Corresponding author. Mailing address: University of Tennessee, Memphis, 956 Court Ave., Suite A-202, Memphis, TN 38163. Phone: (901) 448-7247. Fax: (901) 448-7208. E-mail: mkotb{at}utmem.edu.

Infection and Immunity, November 2000, p. 6362-6369, Vol. 68, No. 11
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Kappeler, K. V., Anbalagan, S., Dmitriev, A. V., McDowell, E. J., Neely, M. N., Chaussee, M. S. (2009). A Naturally Occurring Rgg Variant in Serotype M3 Streptococcus pyogenes Does Not Activate speB Expression Due to Altered Specificity of DNA Binding. Infect. Immun. 77: 5411-5417 [Abstract] [Full Text]  
  • Matsui, H., Sekiya, Y., Nakamura, M., Murayama, S. Y., Yoshida, H., Takahashi, T., Imanishi, K., Tsuchimoto, K., Uchiyama, T., Sunakawa, K., Ubukata, K. (2009). CD46 Transgenic Mouse Model of Necrotizing Fasciitis Caused by Streptococcus pyogenes Infection. Infect. Immun. 77: 4806-4814 [Abstract] [Full Text]  
  • Timmer, A. M., Timmer, J. C., Pence, M. A., Hsu, L.-C., Ghochani, M., Frey, T. G., Karin, M., Salvesen, G. S., Nizet, V. (2009). Streptolysin O Promotes Group A Streptococcus Immune Evasion by Accelerated Macrophage Apoptosis. J. Biol. Chem. 284: 862-871 [Abstract] [Full Text]  
  • Johansson, L., Thulin, P., Sendi, P., Hertzen, E., Linder, A., Akesson, P., Low, D. E., Agerberth, B., Norrby-Teglund, A. (2008). Cathelicidin LL-37 in Severe Streptococcus pyogenes Soft Tissue Infections in Humans. Infect. Immun. 76: 3399-3404 [Abstract] [Full Text]  
  • Kwinn, L. A., Khosravi, A., Aziz, R. K., Timmer, A. M., Doran, K. S., Kotb, M., Nizet, V. (2007). Genetic Characterization and Virulence Role of the RALP3/LSA Locus Upstream of the Streptolysin S Operon in Invasive M1T1 Group A Streptococcus. J. Bacteriol. 189: 1322-1329 [Abstract] [Full Text]  
  • Cole, J. N., McArthur, J. D., McKay, F. C., Sanderson-Smith, M. L., Cork, A. J., Ranson, M., Rohde, M., Itzek, A., Sun, H., Ginsburg, D., Kotb, M., Nizet, V., Chhatwal, G. S., Walker, M. J. (2006). Trigger for group A streptococcal M1T1 invasive disease. FASEB J. 20: 1745-1747 [Abstract] [Full Text]  
  • Peyssonnaux, C., Zinkernagel, A. S., Datta, V., Lauth, X., Johnson, R. S., Nizet, V. (2006). TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107: 3727-3732 [Abstract] [Full Text]  
  • Loughman, J. A., Caparon, M. (2006). Regulation of SpeB in Streptococcus pyogenes by pH and NaCl: a Model for In Vivo Gene Expression. J. Bacteriol. 188: 399-408 [Abstract] [Full Text]  
  • Kristian, S. A., Datta, V., Weidenmaier, C., Kansal, R., Fedtke, I., Peschel, A., Gallo, R. L., Nizet, V. (2005). D-Alanylation of Teichoic Acids Promotes Group A Streptococcus Antimicrobial Peptide Resistance, Neutrophil Survival, and Epithelial Cell Invasion. J. Bacteriol. 187: 6719-6725 [Abstract] [Full Text]  
  • Liu, G. Y., Essex, A., Buchanan, J. T., Datta, V., Hoffman, H. M., Bastian, J. F., Fierer, J., Nizet, V. (2005). Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. JEM 202: 209-215 [Abstract] [Full Text]  
  • Cole, J. N., Ramirez, R. D., Currie, B. J., Cordwell, S. J., Djordjevic, S. P., Walker, M. J. (2005). Surface Analyses and Immune Reactivities of Major Cell Wall-Associated Proteins of Group A Streptococcus. Infect. Immun. 73: 3137-3146 [Abstract] [Full Text]  
  • Zimmerlein, B., Park, H.-S., Li, S., Podbielski, A., Cleary, P. P. (2005). The M Protein Is Dispensable for Maturation of Streptococcal Cysteine Protease SpeB. Infect. Immun. 73: 859-864 [Abstract] [Full Text]  
  • Brussow, H., Canchaya, C., Hardt, W.-D. (2004). Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic Conversion. Microbiol. Mol. Biol. Rev. 68: 560-602 [Abstract] [Full Text]  
  • Engleberg, N. C., Heath, A., Vardaman, K., DiRita, V. J. (2004). Contribution of CsrR-Regulated Virulence Factors to the Progress and Outcome of Murine Skin Infections by Streptococcus pyogenes. Infect. Immun. 72: 623-628 [Abstract] [Full Text]  
  • Neely, M. N., Lyon, W. R., Runft, D. L., Caparon, M. (2003). Role of RopB in Growth Phase Expression of the SpeB Cysteine Protease of Streptococcus pyogenes. J. Bacteriol. 185: 5166-5174 [Abstract] [Full Text]  
  • Collin, M., Olsen, A. (2003). Extracellular Enzymes with Immunomodulating Activities: Variations on a Theme in Streptococcus pyogenes. Infect. Immun. 71: 2983-2992 [Full Text]  
  • Jeng, A., Sakota, V., Li, Z., Datta, V., Beall, B., Nizet, V. (2003). Molecular Genetic Analysis of a Group A Streptococcus Operon Encoding Serum Opacity Factor and a Novel Fibronectin-Binding Protein, SfbX. J. Bacteriol. 185: 1208-1217 [Abstract] [Full Text]  
  • DelVecchio, A., Maley, M., Currie, B. J., Sriprakash, K. S. (2002). NAD-Glycohydrolase Production and speA and speC Distribution in Group A Streptococcus (GAS) Isolates Do Not Correlate with Severe GAS Diseases in the Australian Population. J. Clin. Microbiol. 40: 2642-2644 [Abstract] [Full Text]  
  • Thongboonkerd, V., Luengpailin, J., Cao, J., Pierce, W. M., Cai, J., Klein, J. B., Doyle, R. J. (2002). Fluoride Exposure Attenuates Expression of Streptococcus pyogenes Virulence Factors. J. Biol. Chem. 277: 16599-16605 [Abstract] [Full Text]  
  • Matsunaga, J., Young, T. A., Barnett, J. K., Barnett, D., Bolin, C. A., Haake, D. A. (2002). Novel 45-Kilodalton Leptospiral Protein That Is Processed to a 31-Kilodalton Growth-Phase-Regulated Peripheral Membrane Protein. Infect. Immun. 70: 323-334 [Abstract] [Full Text]  
  • Kazmi, S. U., Kansal, R., Aziz, R. K., Hooshdaran, M., Norrby-Teglund, A., Low, D. E., Halim, A.-B., Kotb, M. (2001). Reciprocal, Temporal Expression of SpeA and SpeB by Invasive M1T1 Group A Streptococcal Isolates In Vivo. Infect. Immun. 69: 4988-4995 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»